Home » Stocks » Genetron Holdings

Genetron Holdings Limited (GTH)

Stock Price: $11.44 USD -0.08 (-0.69%)
Updated Sep 18, 2020 4:00 PM EDT - Market closed
After-hours: $11.31 -0.13 (-1.14%) Sep 18, 6:48 PM

Stock Price Chart

Key Info

Market Cap 1.01B
Revenue (ttm) 47.78M
Net Income (ttm) -99.87M
Shares Out 88.36M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Sep 18, 2020
Last Price $11.44
Previous Close $11.52
Change ($) -0.08
Change (%) -0.69%
Day's Open 11.55
Day's Range 11.30 - 11.62
Day's Volume 62,766
52-Week Range 11.09 - 17.71

More Stats

Market Cap 1.01B
Enterprise Value 982.12M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 88.36M
Float 82.00M
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share -0.36
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 117,582
Short Ratio 2.47
Short % of Float 0.00%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 21.16
PB Ratio 3.54
Revenue 47.78M
Operating Income -45.33M
Net Income -99.87M
Free Cash Flow -31.52M
Net Cash 28.74M
Net Cash / Share 0.33
Gross Margin 44.83%
Operating Margin -94.88%
Profit Margin -209.00%
FCF Margin -65.96%
ROA n/a
ROE n/a
ROIC -280.20%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(74.48% upside)
Current: $11.44
Target: 19.96
*Average 12-month USD price target from 3 stock analysts.

Financial Performance

Financial numbers in millions CNY.

Financial Overview

Revenue Growth43.63%122.87%-
Gross Profit14592.7326.82
Operating Income-307-233-153
Net Income-676-465-421
Shares Outstanding442--
Earnings Per Share-27.05-20.45-23.20
Operating Cash Flow-197-201-130
Capital Expenditures-16.38-43.91-19.17
Free Cash Flow-213-245-149
Cash & Equivalents262101295
Total Debt67.64--
Net Cash / Debt195101295
Book Value-1,778-1,064-622
Numbers in millions CNY, except per-share numbers.

Company Profile

Company Details

Full Name Genetron Holdings Limited
Country China
Employees 697
CEO Si Zhen Wang

Stock Information

Ticker Symbol GTH
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: GTH
IPO Date June 19, 2020


Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early liver cancer screening services through laboratory developed tests services, such as HCCscreen, a proprietary assay for the early screening of liver cancer. It also provides in-vitro diagnostics products, including 8-gene Lung Cancer Assay, an IVD assay product based on semiconductor sequencing to detect lung cancer; Genetron 3D biochip reading instrument; IDH1/TERT gene assays for glioma; GENETRON S5, a semiconductor sequencer used in the field of gene detection; and Genetron S2000 that enables gene panel sequencing. In addition, the company develops ctDNA Lung Cancer assay for mutations in the epidermal growth factor receptor gene. It also offers development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies, hospitals, and research institutions worldwide. The company was founded in 2015 and is headquartered in Beijing, the People's Republic of China. Address: Building 11, Beijing, China, 102206